AstraZeneca Pharma India has informed that a meeting of the board of directors of the company will be held on May 21, 2013, for considering Audited Financial Results of the Company, for the last quarter and financial year ended March 31, 2013 and may also consider recommendation of dividend for the financial year ended March 31, 2013.
The above information is a part of company’s filings submitted to BSE.